ConductScience.org, home

Paper17547502

Piperacillin-tazobactam: a beta-lactam/beta-lactamase inhibitor combination.

Gin A and 5 others. Expert Rev Anti Infect Ther, 2007. Cited by 106 papers, by iCite.

Cite this record

ConductScience Library. Piperacillin-tazobactam: a beta-lactam/beta-lactamase inhibitor combination. Papers, record 17547502. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17547502

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Piperacillin-tazobactam: a beta-lactam/beta-lactamase inhibitor combination.
PubMed
Journal
Expert Rev Anti Infect Ther
PubMed
Year
2007
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
106
iCite
Relative citation ratio, by iCite
3.32
iCite
Revised in PubMed
2018-12-01
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gin AAlfred
2Dilay LLeanne
3Karlowsky JAJames A
4Walkty AAndrew
5Rubinstein EEthan
6Zhanel GGGeorge G

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
beta-Lactamase InhibitorsMajor topic
Clinical Trials as Topic
Drug Resistance, Bacterial
Humans
Microbial Sensitivity Tests
Neutropenia
Penicillanic Acid
Piperacillin
Piperacillin, Tazobactam Drug Combination
Pneumonia, Bacterial
Randomized Controlled Trials as Topic
Soft Tissue Infections

Source PubMed

Download CSV of topics

Cited by62

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 106 citations.

PMIDTitleJournalYearIn PapersSource
42989114Effects of common antibiotics on representative gut bacterial strains associated with inflammatory bowel disease.BMC Microbiol2026https://conductscience.org/library/papers/42989114PubMed
42592029Anaphylactic Shock Probably due to a Cross-Reaction Between Cefuroxime and Piperacillin-Presentation of a Fatal Case, Diagnostic Considerations, and Literature Review.Case Rep Crit Care2026https://conductscience.org/library/papers/42592029PubMed
42556984Antibiotic Therapy for the Prevention and Treatment of Neonatal Sepsis.Clin Perinatol2026https://conductscience.org/library/papers/42556984PubMed
42477084Comparative analysis of cefoperazone-sulbactam and piperacillin-tazobactam in empirical treatment of acute biliary tract infections: a multicenter, retrospective, real-world study.Sci Rep2026https://conductscience.org/library/papers/42477084PubMed
42256409Thrombocytopenia and anemia associated with piperacillin-tazobactam: integrating clinical case series with FAERS disproportionality analysis.Front Pharmacol2026https://conductscience.org/library/papers/42256409PubMed
42112094Optimal Piperacillin/Tazobactam Dosing in Adults with Low Body Weight: A Population Pharmacokinetic and Simulation-Based Study.Drug Des Devel Ther2026https://conductscience.org/library/papers/42112094PubMed
41889519Piperacillin-tazobactam-associated thrombocytopenia with negative antiplatelet antibody testing: a case report and literature review.Front Med (Lausanne)2026https://conductscience.org/library/papers/41889519PubMed
41715151Evaluation of piperacillin-tazobactam appropriateness and underlying drivers of inappropriate prescribing in a Belgian University Hospital: a retrospective study.Antimicrob Resist Infect Control2026https://conductscience.org/library/papers/41715151PubMed
40823816Piperacillin reaches high concentrations in bile and target tissues of the biliary system: an experimental study in pigs.Antimicrob Agents Chemother2025https://conductscience.org/library/papers/40823816PubMed
40657038Unfolding the collective functional potential of a synergistic multispecies community through genotypic and phenotypic analyses.Biofilm2025https://conductscience.org/library/papers/40657038PubMed
40504338Antibiotic-related dysbiosis of gut microbiota in healthy volunteers: a comparative study of ceftazidime-avibactam, piperacillin-tazobactam, and ceftriaxone.Eur J Clin Microbiol Infect Dis2025https://conductscience.org/library/papers/40504338PubMed
40212240Ionizable Lipid Containing Nanocarriers for Antimicrobial Agent Delivery.Small Sci2024https://conductscience.org/library/papers/40212240PubMed
39722108A Pooled Pharmacokinetic Analysis for Piperacillin/Tazobactam Across Different Patient Populations: From Premature Infants to the Elderly.Clin Pharmacokinet2025https://conductscience.org/library/papers/39722108PubMed
39695560Antibiotics versus Non-Antibiotic in the treatment of Aspiration Pneumonia: analysis of the MIMIC-IV database.BMC Pulm Med2024https://conductscience.org/library/papers/39695560PubMed
39635712A pharmaceutical policy accident: collision of shareholder capitalism and Chinese state capitalism driving the shortage of an essential antibiotic.J Pharm Policy Pract2024https://conductscience.org/library/papers/39635712PubMed
39501680Fungal dysbiosis following antibacterial monotherapy in canine otitis externa.J Small Anim Pract2025https://conductscience.org/library/papers/39501680PubMed
39248479Characterization of acquired β-lactamases in Pseudomonas aeruginosa and quantification of their contributions to resistance.Microbiol Spectr2024https://conductscience.org/library/papers/39248479PubMed
39107511An investigation of broad-spectrum antibiotic-induced liver injury based on the FDA Adverse Event Reporting System and retrospective observational study.Sci Rep2024https://conductscience.org/library/papers/39107511PubMed
39081458Extended Spectrum beta-Lactamase Bacteria and Multidrug Resistance in Jordan are Predicted Using a New Machine-Learning system.Infect Drug Resist2024https://conductscience.org/library/papers/39081458PubMed
38391033Advancements in colorectal cancer research: Unveiling the cellular and molecular mechanisms of neddylation (Review).Int J Oncol2024https://conductscience.org/library/papers/38391033PubMed

See all 62 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17547502

GET https://conductscience.org/api/papers/v1/17547502/cited_by?page=2